Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment for these indications is innovative (“off-label”). Please see the Terms of Use. The method of off-label treatment utilized is a patented invention of the INR. Copyright 2018 INR PLLC, all rights reserved.
Posted by INR PLLC on Thursday, February 16, 2017 at 12:14 pm
Filed under Blog Posts, Brain Research, INR News, Uncategorized · Tagged with Anti-Inflammatory, Chronic Post-Stroke Pain, Dr. Edward Tobinick, Etanercept, Inflammation, INR PLLC, Institute of Neurological Recovery, Pain, Perispinal, Perispinal Etanercept, Post Stroke Pain, Stroke, TNF, TNFa, Tobinick, Tumor Necrosis Factor Alpha
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment for these indications is innovative (“off-label”). Please see the Terms of Use. The method of off-label treatment utilized is a patented invention of the INR.
Posted by INR PLLC on Friday, September 16, 2016 at 12:12 pm
Filed under Blog Posts, Brain Research, INR News, Uncategorized · Tagged with Anti-Inflammatory, Chronic Post-Stroke Pain, Dr. Edward Tobinick, Etanercept, Inflammation, INR PLLC, Institute of Neurological Recovery, Pain, Perispinal, Perispinal Etanercept, Post Stroke Pain, Stroke, TNF, TNFa, Tobinick, Tumor Necrosis Factor Alpha
